Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
"1113760292"
Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
66.99 In Stock
Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

eBook

$66.99  $88.99 Save 25% Current price is $66.99, Original price is $88.99. You Save 25%.

Available on Compatible NOOK devices, the free NOOK App and in My Digital Library.
WANT A NOOK?  Explore Now

Related collections and offers


Overview

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.

Product Details

ISBN-13: 9781455750597
Publisher: Elsevier Health Sciences
Publication date: 11/28/2012
Series: The Clinics: Internal Medicine , #38
Sold by: Barnes & Noble
Format: eBook
Pages: 240
File size: 4 MB
From the B&N Reads Blog

Customer Reviews